copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Home Page - Cypre Cypre builds immune and stroma competent organoids that aim to recreate the complexity of disease in a standardized and high throughput screening format
Cypre | What we do | Home - bp The Cypre project was pleased to announce the successful completion of its Phase 1 startup in the first quarter of 2025, marking a significant step forward in the development of this world-class energy asset
Cypre Inc. - BIO International Convention 2025 Cypre builds next-generation tumor organoids that decode immune and stromal response for oncology drug development Our immune-integrated platform combines human tumor, fibroblast, and immune cells to model complex tumor microenvironment biology – enabling high-content phenotypic screening, MOA discovery, and immune-modulated response analytics
Cypre - Crunchbase Company Profile Funding Cypre Inc is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery
Resources - Cypre Cypre co-presented a webinar with Charles River titled “Predict Anticancer Efficacy with a New In Vitro 3D Modeling Platform” The webinar is now available on-demand through the link below
bpTT announces start of production from new Cypre gas project bp Trinidad and Tobago (bpTT) today confirms its Cypre development has safely delivered its first gas Cypre is one of bp’s 10 major projects expected to start up worldwide between 2025 and 2027, announced as part of bp’s reset strategy to grow the upstream